Atomwise vs Insilico Medicine

Side-by-side comparison of Atomwise and Insilico Medicine: pricing, features, API access, and community ratings.

AI comparison summary

Generating comparison…

	Atomwise AI superplatform that explores chemical space to discover novel, drug-like molecules Visit	Insilico Medicine Generative AI platform for end-to-end drug discovery, from target identification to clinical trials Visit
Category	Healthcare & biotech	Healthcare & biotech
Pricing	Enterprise	Enterprise
Starting price
Free tier
Audience	Technical	Technical
API available
Open source
Self-hostable
Model provider	Proprietary ML (AtomNet)	Insilico Medicine (proprietary LLLMs)
Founded	2012	2014
Headquarters	San Francisco, USA	Cambridge, USA
Key strengths	·AI-driven small-molecule drug discovery ·Exploration of vast chemical space beyond traditional screening ·Focus on first- and best-in-class immune/inflammatory disease programs ·Proprietary deep learning models for molecular binding prediction	·End-to-end AI-driven drug discovery pipeline (target ID to clinical trials) ·Generative chemistry and biology AI (Chemistry42, Generative Biologics) ·Large Language of Life Models (LLLMs) for biomedical research ·Validated therapeutic pipeline with programs in Phase I/II trials